Literature DB >> 519221

De novo acute infection and reactivation of hepatitis B virus in established cirrhosis.

A Theodossi, S P Wilkinson, B Portmann, Y White, A L Eddleston, R Williams, A J Zuckerman.   

Abstract

Five patients with cirrhosis proved by biopsy had clinical, biochemical, and serological evidence of an acute hepatitis B infection. In two the illness was fulminant and led to death. Only one patient completely recovered. Serological markers for the hepatitis B virus were absent before the onset of the acute illness in four patients, which suggested that a de novo infection had been acquired as a result of recent transfusions of blood or blood products. The fifth patient, who had Goodpasture's syndrome, had antibody to the core of hepatitis B virus, indicating previous exposure to the virus; his acute hepatitis may have been related to immunosuppressive drug treatment, which may have reactivated a dormant virus infection. Thus an acute type B viral hepatitis due to either a de novo or a reactivated infection may be superimposed on cirrhosis.

Entities:  

Mesh:

Year:  1979        PMID: 519221      PMCID: PMC1596746          DOI: 10.1136/bmj.2.6195.893

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  7 in total

1.  The development of HBsAg-positive hepatitis despite the previous existence of antibody to HBsAg.

Authors:  D E Koziol; H J Alter; J P Kirchner; P V Holland
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

2.  Antibody to hepatitis-B-virus core in man.

Authors:  J H Hoofnagle; R J Gerety; L F Barker
Journal:  Lancet       Date:  1973-10-20       Impact factor: 79.321

3.  Detection of HBSAG in fixed liver tissue - use of a modified immunofluorescent technique and comparison with histochemical methods.

Authors:  B Portmann; R M Galbraith; A L Eddleston; A J Zuckerman; R Williams
Journal:  Gut       Date:  1976-01       Impact factor: 23.059

4.  Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen.

Authors:  J H Hoofnagle; L B Seeff; Z B Bales; H J Zimmerman
Journal:  N Engl J Med       Date:  1978-06-22       Impact factor: 91.245

5.  Transmission of non-A non-B hepatitis to chimpanzees by factor-IX concentrates after fatal complications in patients with chronic liver disease.

Authors:  R J Wyke; K N Tsiquaye; A Thornton; Y White; B Portmann; P K Das; A J Zuckerman; R Williams
Journal:  Lancet       Date:  1979-03-10       Impact factor: 79.321

6.  Reactivation of hepatitis b after transplantation operations.

Authors:  J Nagington
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

7.  Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders.

Authors:  J R Wands; C M Chura; F J Roll; W C Maddrey
Journal:  Gastroenterology       Date:  1975-01       Impact factor: 22.682

  7 in total
  3 in total

Review 1.  Natural history of the HBsAg carrier.

Authors:  M G Anderson; I M Murray-Lyon
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

2.  The clinical course of acute type A hepatitis in chronic HBsAg carriers--a report of 3 cases.

Authors:  L A Viola; I G Barrison; J C Coleman; I M Murray-Lyon
Journal:  Postgrad Med J       Date:  1982-02       Impact factor: 2.401

3.  Importance of markers of hepatitis B virus in alcoholic liver disease.

Authors:  J B Saunders; A D Wodak; P Morgan-Capner; Y S White; B Portmann; M Davis; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.